Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: highly effective in a predominantly black male patient population | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: highly effective in a predominantly black male patient population

Tang L, Parker A, Flores Y, et al. Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: highly effective in a predominantly black male patient population. J Viral Hepat. 2018;25(2):205-208.

Publication Type:

Journal Article

Authors:

Tang, L; Parker, A; Flores, Y; et, al

Source:

J Viral Hepat, Volume 25, Issue 2, p.205-208 (2018)

Cited On:

Export Citation:

RIS Format

Top